10x Genomics PER
¿Qué es el PER de 10x Genomics?
El PER de 10x Genomics, Inc. es N/A
¿Cuál es la definición de PER?
La relación precio/ganancias es la relación entre el precio de las acciones de una compañía y las ganancias por acción de la compañía calculadas en los últimos doce meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
PER de compañías en Sector Health Care en NASDAQ en comparadas con 10x Genomics
¿Qué hace 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Empresas con per similar a 10x Genomics
- Motorpoint Plc tiene PER de N/A
- Laramide Resources tiene PER de N/A
- UCW tiene PER de N/A
- First Shanghai Investments tiene PER de N/A
- Falco Resources tiene PER de N/A
- Symphony tiene PER de N/A
- 10x Genomics tiene PER de N/A
- SGOCO Ltd tiene PER de N/A
- Dr. Hönle AG tiene PER de N/A
- Forebase International tiene PER de N/A
- Wuhan Xingtu Xinke Electronics Co tiene PER de N/A
- Kayne Anderson NextGen & Infrastructure Inc tiene PER de N/A
- Alliance Resources tiene PER de N/A